Cleerly ISCHEMIA vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly ISCHEMIA

by Cleerly

Study Watch with Irregular Pulse Monitor (Home)

by Verily Health

AI Verdict

Cleerly ISCHEMIA is an AI-powered diagnostic tool that analyzes CCTA scans to assess coronary artery ischemia, plaque, and stenosis, aiding in the diagnosis of coronary artery disease. In contrast, the Verily Study Watch is a wearable device for remote physiological monitoring, primarily focused on detecting irregular pulses and atrial fibrillation through ECG and other sensors. While both tools apply AI in cardiology, they address different aspects of cardiovascular health: one for advanced imaging diagnostics of coronary arteries and the other for continuous cardiac rhythm monitoring.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a precise, non-invasive diagnostic assessment of coronary artery disease, particularly when evaluating patients with suspected ischemia or complex plaque morphology. This tool is ideal for physicians seeking detailed vessel-level insights from CCTA scans, including fractional flow reserve estimation and comprehensive plaque characterization, to inform personalized treatment strategies.

View Cleerly ISCHEMIA →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch with Irregular Pulse Monitor (Home) if you require continuous, unobtrusive physiological data collection for clinical research or long-term remote monitoring of patients. This prescription-only wearable is best suited for detecting irregular pulses indicative of conditions like atrial fibrillation and gathering extensive sensor data outside of a traditional clinical setting.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly ISCHEMIA	Study Watch with Irregular Pulse Monitor (Home)
Deployment	Web-based solution	Unknown
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly ISCHEMIA	Study Watch with Irregular Pulse Monitor (Home)
Primary Function	Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level.	Wearable device for unobtrusive collection of physiological data, including ECG and irregular pulse monitoring.
Core Data Input/Technology	AI-enabled CCTA analysis	On-demand single-channel ECG measurement, multiple physiological sensors (heart rate, electrodermal activity, inertial movements), environmental sensors.
Key Output/Detection	Vessel-level ischemia likelihood determination, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization, stenosis severity assessment.	Irregular pulse monitoring for atrial fibrillation (AFib) detection, on-demand single-channel ECG measurement.
Target Medical Specialties	Cardiology, Radiology	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of Cleerly ISCHEMIA versus the Verily Study Watch?

Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring for atrial fibrillation (AFib) detection.

How do these tools acquire patient data?

Cleerly ISCHEMIA analyzes data from coronary computed tomography angiography (CCTA) scans. The Verily Study Watch collects data via a wearable device with multiple physiological sensors (heart rate, electrodermal activity, inertial movements) and environmental sensors, including on-demand single-channel ECG measurement capabilities.

What specific diagnostic insights do these tools provide to a physician?

Cleerly ISCHEMIA provides vessel-level ischemia likelihood determination, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization (volume, type, location), and stenosis severity assessment, presented in comprehensive interactive web-based reports. The Verily Study Watch offers on-demand single-channel ECG measurements and irregular pulse monitoring for AFib detection, with data processed using proprietary algorithms and machine learning in the cloud.

Are there any specific compliance or data privacy considerations a physician should be aware of for either tool?

Cleerly ISCHEMIA is FDA-cleared, HIPAA compliant, and has a Business Associate Agreement (BAA). While Verily states its services may be subject to HIPAA and it may act as a 'business associate,' a lawsuit alleging HIPAA breaches in past operations has been reported.

What medical specialties are these tools primarily designed for?

Cleerly ISCHEMIA is primarily designed for Cardiology and Radiology specialties. The Verily Study Watch is intended for Cardiology, Family Medicine, and Internal Medicine.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly ISCHEMIA or Study Watch with Irregular Pulse Monitor (Home)

Backers

Who funded each tool's parent company.